The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.
Tuberculosis (Edinb)
; 112: 98-109, 2018 09.
Article
in En
| MEDLINE
| ID: mdl-30205975
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rifampin
/
Bacterial Proteins
/
DNA-Directed RNA Polymerases
/
Antibiotics, Antitubercular
/
Mycobacterium tuberculosis
/
Naphthyridines
/
Antimalarials
/
Antitubercular Agents
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Tuberculosis (Edinb)
Year:
2018
Document type:
Article
Affiliation country:
Italia
Country of publication:
Reino Unido